Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Tapentadol
Drug ID BADD_D02115
Description Opioid analgesic for treatment of moderate to severe pain. FDA approved on Nov 20, 2008.
Indications and Usage The immediate-release formulation of tapentadol is indicated for the relief of moderate to severe acute pain. The long-acting formulation serves as a continuous, around-the-clock analgesic that is indicated for the relief of moderate to severe chronic pain or neuropathic pain associated with diabetic peripheral neuropathy.
Marketing Status approved
ATC Code N02AX06
DrugBank ID DB06204
KEGG ID D06007
MeSH ID D000077432
PubChem ID 9838022
TTD Drug ID D0K4MH
NDC Product Code Not Available
UNII H8A007M585
Synonyms Tapentadol | 3-((1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl)phenol | Nucynta | Tapentadol Hydrochloride
Chemical Information
Molecular Formula C14H23NO
CAS Registry Number 175591-23-8
SMILES CCC(C1=CC(=CC=C1)O)C(C)CN(C)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abnormal dreams19.02.03.001; 17.15.02.0010.005479%Not Available
Aggression19.05.01.0010.002230%Not Available
Agitation19.06.02.001; 17.02.05.0120.006116%
Akathisia19.06.02.006; 17.01.02.0020.001402%
Altered state of consciousness19.07.01.003; 17.02.04.0010.002548%Not Available
Amnesia19.20.01.001; 17.03.02.0010.005160%
Anaphylactic reaction24.06.03.006; 10.01.07.0010.001274%
Aneurysm24.02.01.0010.000637%Not Available
Anxiety19.06.02.0020.017583%
Apnoea22.02.01.0010.001911%
Arrhythmia02.03.02.0010.000956%Not Available
Aspiration22.02.07.0070.000637%
Asthma22.03.01.002; 10.01.03.0100.002803%Not Available
Ataxia17.02.02.001; 08.01.02.0040.000637%
Bladder pain20.02.02.0010.001402%Not Available
Bradycardia02.03.02.0020.001911%Not Available
Cardio-respiratory arrest22.02.06.007; 02.03.04.0020.000956%Not Available
Chromaturia20.02.01.0020.001402%
Chronic obstructive pulmonary disease22.03.01.0070.001720%Not Available
Coma17.02.09.0010.001911%Not Available
Confusional state19.13.01.001; 17.02.03.0050.010894%
Constipation07.02.02.0010.010066%
Coordination abnormal17.02.02.0040.000637%Not Available
Crying19.04.02.002; 17.02.05.013; 12.02.11.001; 08.01.03.0050.002803%Not Available
Delirium19.13.02.0010.009237%
Delusion19.10.01.0010.004396%
Depressed level of consciousness17.02.04.0020.002548%
Depressed mood19.15.02.0010.000956%Not Available
Diplegia17.01.04.0150.000637%Not Available
Disorientation19.13.01.002; 17.02.05.0150.001274%Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 6 Pages